SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-022092
Filing Date
2020-02-14
Accepted
2020-02-14 18:00:35
Documents
2
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm208184-5_form5.html 5  
1 OWNERSHIP DOCUMENT tm208184-5_form5.xml 5 5173
2 EXHIBIT 24 tm208184-5_ex24.htm EX-24 7009
  Complete submission text file 0001104659-20-022092.txt   13779
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TARGETED GENETICS CORP 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address
COOK JEREMY CURNOCK (Reporting) CIK: 0001216486 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-37544 | Film No.: 20622348